ASCO 2022 Conference Coverage
S

ASCO 2022 Phase 2 Study of Lasofoxifene + Abemaciclib for Treating Pre-/Post-Menopausal Women With Locally Advanced/Metastatic ER+/HER2- BC and an ESR1 Mutation After Progression on Prior Therapies

By ASCO 2022 Conference Coverage FEATURING Senthil Damodaran
By ASCO 2022 Conference Coverage FEATURING Senthil Damodaran
275 views
June 30, 2022
Comments 0
Login to view comments. Click here to Login

Related Videos

Total Health

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025
08:05

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

2.5K views
08:35

Year in Review 2024: Top Metastatic Breast Cancer Trials

Oncology 2024 Year in Review

V. Kaklamani

1.9K views
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

1.5K views
21:18

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

1.1K views
25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

5.3K views
15:57

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

1.2K views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.6K views
14:36

SABCS 2024 Insights: PATINA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

687 views
05:56

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

616 views
12:14

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.5K views
05:07

SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx

2024 SABCS Annual Meeting Insights Hub

V. Kaklamani

505 views
17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.9K views
02:22

SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy…

2024 SABCS Annual Meeting Insights Hub

E. Hamilton

394 views
15:44

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

517 views
10:53

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

Kirollos Hanna

2.4K views
12:24

SABCS 2024 Insights: PADMA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

384 views
17:56

New

Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC fo…

2024 SABCS Annual Meeting Insights Hub

S. Hurvitz

348 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

739 views
23:56

Current Unmet Needs in HR+/HER2- eBC: Assessing Risk of Recurrence, …

Julia Foldi

338 views
04:03

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

587 views
AUTOPLAY